Intervention with Specific Bacterial Immunotherapy in Patients with Recurrent Infections. (Original)
Keywords:
immunotherapy; pharyngotonsillitis; bronchial asthmaAbstract
A quasi-experimental intervention study was carried out in the consultation of the allergy service of the Gustavo Aldereguía Lima Polyclinic of the Las Tunas municipality, in the period from September 2019 to March 2021 with the aim of evaluate the efficacy of bacterial immunotherapy in the treatment of the atopic patient with recurrent infections in routine clinical practice. The sample consisted of 114 patients between the ages of 5 and 59 years. The patients underwent allergen-specific bacterial therapy and were followed for one year. The level of disease control was established at the start of treatment and at each follow-up visit as a measure of efficacy, and the main associated adverse effects were described. In the study, patients between 10-19 years predominated for 30,70%. 43,86% of the patients studied had a history of bronchial asthma, this being the most reported entity in our research followed in order of prevalence allergic rhinitis with 39 cases. The most common recurrent infection was pharyngotonsillitis with 53, 5% and the most frequent germ isolated was streptococcus for 40,3%. The results obtained allow us to affirm that specific bacterial immunotherapy has a good efficacy and safety profile, reaching 25, 87 in the last determinations and only 11, 4% presented mild local adverse reactions.
Downloads
References
Bernstein, J., Bouillet, L., Caballero, T. y Staevsa, M. (2021). Efectos hormonales sobre las condiciones de urticaria y angioedema. The Journal of Allergy and Clinical Immunology: In practice. Recuperado de: https://doi.org/10.1016/j.jaip.2021.04.021
Bess, S. (2019). Anuario Estadístico de Cuba. [Soporte digital]. Recuperado de: http://bvscuba.sld.cu/anuario-estadistico-de-cuba/en
Boulet, L., Bateman, E., Brusselle, G., Cruz, A., FitzGerald, J., Inove, H y Sheikh, A. (2019) Global Initiative for Asthma (GINA). Global Strategy for Asthma Management and Prevention. [Soporte digital]. Recuperado de: https://ginasthma.org/wp-content/uploads/2019/06/GINA-2019-main-report-June-2019-wms.pdf
Campell, D. y Kemp, A. (1997). Proliferation and production of interferon gamma and IL 4 in response to staphilococealsuperantigen and staphilococcusaureus in chilhoodatópic dermatitis. Clin. ExpImmunol 107(2), 392-7. Recuperado de: https://pubmed.ncbi.nlm.nih.gov/9030880/
García, I., Alvarez, M. y Rodríguez, P. (2008). Experiencias clínicas con vacunas bacterianas en linfangitis, colitis y sepsis urinaria. Rev Científico Estudiantil de las Ciencias Médicas de Cuba [Soporte digital]. Recuperado de: http://www.16deabril.sld.cu/rev/213/profe.html.
Hernández, S., Rodríguez, M., Machín, M., García, A, y Prat, I. (2015). Tratamiento del asma bronquial en niños según la medicina Bioenergética y Natural. Revista de Ciencias Médicas de Pinar del Río, 19(2), 374-394.
Kou, W., Li, X., Yao, H. y Wei, P. (2018). Meta-analysis of the comorbidity rate of allergic rhinitis and asthma in Chinese children. Int J Pediatr Otorhinolaryngol 107: 131-34. [Soporte digital]. Recuperado de: https://pubmed.ncbi.nlm.nih.gov/29501293/
López, R., Huerta, R. y Frías, M. (2017). Sensibilización a alérgenos en pacientes pediátricos mayores de 2 años en el Hospital Infantil del Estado de Sonora. Bol Clin Hosp Infant Edo Son. 34(2), 90-96. Recuperado de: https://www.medigraphic.com/pdfs/bolclinhosinfson/bis-2017/bis172d.pdf
Martín, A., Quezada, H. y Becerril, G. (2016). Recent advances in novel antibacterial development. Frontiers in Clinical Drug Research: Anti-Infectives [Soporte digital]. Recuperado de: https://www.researchgate.net/publication/301358410_Recent_Advances_in_Novel_Antibacterial_Development
Middleton, E., Reed, C., Ellis, E., Adkinson, N., Yunginger, J. y Busse, W. (1998) Cell-mediatedimmunity in healthanddisease. En: Allergy, principlesandpractice, editores, 5° ed, St. Louis, Mosby 8: 685-701. Recuperado de: https://www.amazon.com/Allergy-Principles-Practice-2-Set/dp/0815100728
Monde, C., Machado, E. y Nicolau, E. (2016). Inmunoterapia bacteriana en pacientes asmáticos con componente infectivo. Tecnosalud. Recuperado de: http://www.tecnosalud2016.sld.cu/index.php/tecnosalud/2016/paper/view/105/52
Naranjo, S., García, R., Naranjo, L. y Negret, M. (2011). Empleo de inmunoterapia en pacientes con infección producida por Staphylococcus aureus. Revista Médica Electrónica 3(2).
Pawankar, R., Canonica, G., Holgate, S. y Lockey, R. (2012). Allergic diseases and asthma: a major global health concern. CurrOpin Allergy ClinImmunol 12(1):39-41.
Rieker, J., Nell, M., Diamant, Z., Van, R., Distler, A., Boot, J. y Kleine, J. (2013). Open-label parallel dose tolerability study of three subcutaneous immunotherapy regimens in house dust mite allergic patients. ClinTransl Allergy 3(1), 16. Recuperado de: https://doi: 10.1186/2045-7022-3-16
Rodríguez, O. y Reyes, M. (2015). Eficacia y seguridad de la inmunoterapia sublingual en niños de 6 a 24 meses de edad con rinitis y asma bronquial sensibilizados a los ácaros domésticos. Vaccimonitor 24(2).
Wholey, W., Kochan, T., Storck, D. y Dawid, S. (2016). Coordinated bacteriocin expression and competence in Streptococcus pneumoniae contributes to genetic adaptation through neighbor predation. PLoSPathog 12. Recuperado de: https://journals.plos.org/plospathogens/article?id=10.1371/journal.ppat.1005413
Yukselen, A., Kendirli, S., Yilmaz, M., Altintas, D. y Karakoc, G. (2014). Correlation between nasal eosinophils and nasal airflows in children with asthma and/or rhinitis monosensitised to house dust mites. Allergol Immunopathol 42(1). Recuperado de: https://pubmed.ncbi.nlm.nih.gov/23122003/
